The Future of EDC in Clinical Trials

The Future of EDC in Clinical Trials

If you need an EDC system for your clinical trial, please contact us at info@klindat.com

As the clinical trials industry continues to evolve, the future of electronic data capture (EDC) systems is becoming increasingly important.

EDC has come a long way since its introduction, and it is now poised to revolutionize the way clinical trials are conducted.

With advancements in technology and the need for more efficient and effective data management, the future of EDC in clinical trials is bright.

The Evolution of EDC Systems

EDC systems have been a part of the clinical trial ecosystem for several decades, initially serving as a tool to capture data recorded on paper during patient visits at research sites.

However, as trials have become more decentralized and data collection methods have diversified, the limitations of traditional EDC systems have become apparent.

In the past, EDC systems lacked the ability to capture data in real-time and often required patients to visit research sites.

This posed challenges for remote or virtual trials, where patients may not be physically present at a clinical site.

To address these limitations, the industry turned to innovative solutions that could capture data from various electronic sources in real-time.

The Rise of eSource Solutions

To overcome the shortcomings of traditional EDC systems, purpose-built eSource solutions have emerged.

These solutions enable direct data capture from multiple sources, such as eConsent forms, patient reported outcomes (PRO), eDiaries, laboratory reports, imaging, and data from wearables.

This comprehensive approach to data capture provides a real-time view of the patient, regardless of their physical location.

eSource solutions have revolutionized the efficiency of data capture, recording, verification, and sharing in clinical trials.

These tools reduce bottlenecks, enable remote review of source data, support real-time edit checks for cleaner data entry, and minimize data queries.

The result is a reduction in patient and site burden, improved data quality, and accelerated database lock, ultimately leading to more efficient and cost-effective clinical trials.

The Power of Direct Data Capture

One of the most exciting developments in the future of EDC is direct data capture, which involves capturing electronic data directly from patient devices and other systems.

This eliminates the need for manual data entry or the downloading of data from patient devices, enabling real-time access to remotely captured data.

The adoption of direct data capture is expected to increase significantly in the coming years, with an average predicted increase from 17% to 34% of EDC trials [1].

Direct data capture offers numerous benefits, including faster data availability, reduced reconciliation time, and improved patient outcomes.

By capturing data directly from the source, such as smartphones, tablets, or wearables, the need for data transcription and manual integration processes is eliminated.

This not only saves time but also reduces the potential for errors and inconsistencies in the data.

The Importance of Data Integration and Standardization

As technology continues to advance, the importance of data integration and standardization becomes paramount.

EDC users and clinical trial technology providers alike recognize the need for seamless and instant integration of data across various systems.

Just as consumers expect data integration in their everyday lives, clinical trial technology should provide the same level of connectivity and interoperability.

In response to this need, the Clinical Data Interchange Standards Consortium (CDISC) was established in the late 1990s.

CDISC developed global standards to streamline clinical research and enable information system interoperability.

These standards have gained broad acceptance throughout the industry and provide a standard backbone for EDC applications.

With the widespread adoption of CDISC standards, EDC applications have evolved to encompass the entire eClinical landscape.

These applications now go beyond data collection and handling to include third-party laboratory results, coding systems, safety systems, and clinical trial management systems.

The integration of these components enhances the efficiency and effectiveness of clinical trials, leading to improved patient outcomes.

The Growing Acceptance and Adoption of EDC

The future of EDC looks promising, as its acceptance and adoption continue to grow within the clinical trials industry.

An estimated 70% of all active clinical trials are currently using EDC in some capacity, indicating its widespread acceptance [2].

Regulatory bodies, including the FDA, have embraced EDC and have mandated the use of CDISC standards in new drug submissions.

While EDC adoption has been significant in many parts of the world, there are still areas where its acceptance lags, such as China and India.

However, regulatory oversight in these regions is evolving rapidly, and guidelines on the use of data standards are being defined.

As compliance with CDISC standards becomes mandatory, the landscape of EDC vendors in these regions will change, leading to increased adoption of compliant applications.

The Future of ePRO in Clinical Trials

Looking ahead, the future of EDC lies in embracing technological advancements and leveraging the power of interconnected systems.

As electronic health records (EHR) become more prevalent, there will be a need for standards to normalize data structures and ensure the security of personal information.

The quality standards for data collected through EHRs will also need to be defined and accepted throughout the industry.

The next evolution in EDC applications will likely involve virtualizing the clinical trial process.

Direct entries of clinical data are already being conducted and represent a rapidly evolving segment of the industry.

To fully leverage the potential of EDC, companies must focus on unifying clinical databases to facilitate easy access and review of data.

Conclusion

In conclusion, the future of EDC in clinical trials is bright, with technology driving advancements in data capture, integration, and standardization.

As the industry embraces these innovations, clinical trials will become more efficient, cost-effective, and patient-centric.

By leveraging the power of EDC and staying at the forefront of technological advancements, the industry can continue to deliver meaningful treatments to those in need.

If you need an EDC system for your clinical trial, please contact us at info@klindat.com

References:

[1] The Future of EDC Systems

[2] A Brief History & Look at the Future of Electronic Data Capture

Share This Post

More To Explore